Meet your clinical, economic, and regulatory needs throughout a product's lifecycle using U.S. real world solutions.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSWith clinical innovation accelerating, more drugs are obtaining marketing authorization for narrowly defined patient populations and early-stage disease. This can pose challenges in clinical evidence development, as fewer patients may be available for recruitment and generating mature outcomes can be prohibitively long.
Real-world evidence (RWE) has the potential to fill this gap by complementing and supplementing clinical trial evidence, as well as reducing health technology assessment (HTA) body uncertainties that can delay reimbursement decisions. As the momentum around RWE use strengthens, examples emerge where it has contributed to positive reimbursement decisions and therefore patient access to innovative therapies. However, acceptance of RWE in HTA evaluations and its impact on HTA outcomes remains limited and highly variable among countries.
This report explores the use of RWE in HTA evaluations to inform factors that are critical to the final pricing and reimbursement decision. It presents an overview of the current role of RWE in oncology HTAs, where unmet need and obstacles to developing clinical evidence are particularly high. The report then explores key drivers and barriers of historic RWE acceptance, which builds upon work presented at ISPOR Europe 2022 of 20 examples in oncology where RWE contributed to a positive HTA outcome. Considering the value of RWE in overcoming payer uncertainties and allowing for faster patient access, the report concludes with a discussion of initiatives and strategies to standardize and optimize the way RWE is evaluated across Europe.
Meet your clinical, economic, and regulatory needs throughout a product's lifecycle using U.S. real world solutions.
Drive better care and greater efficiency through deep, actionable insights.